Noah C. Goldstein

Midyear Update On Recent OIG Activity For Life Sciences Legal And Compliance Professionals (Part 1)

Settlement Renews Focus On Speaker Program Compliance; Complaint Highlights Additional Compliance Considerations

New Year, New Recommendations: FDA Finalizes SIUU Guidance

Clinical Trial Recruitment: Who Are You Paying And What Are You Saying? – Clinical Leader

OIG's New General Compliance Program Guidance (GCPG): Overview And Takeaways For Life Sciences Companies

The More Things Change, The More They Stay The Same: Government Scrutiny Of Financial Arrangements Continues